- Thread Author
- #1
- Joined
- Sep 29, 2023
- Messages
- 842
- Reaction score
- 128
- Trophy Points
- 4
- Location
- Morganton, NC
- D Bucks
- 💵2.389600
- Referral Credit
- 0
(The Guardian) Vaccine panel votes to restrict hepatitis B vaccines shot for newborns in major shift
The CDC’s vaccine advisers have voted 8-3 to remove the broad recommendation that all newborns in the US receive a hepatitis B vaccine, in a major move signaling the Trump administration’s regressive approach to vaccines that have been given safely and effectively for decades.
The committee voted to recommend that parents of infants whose mothers test negative for hepatitis should decide when – or if – their child should receive the vaccine series, after consulting a healthcare professional.
The move will add confusion to routine vaccinations and create access issues, especially for lower-income families, experts said. While the advisers make non-binding recommendations, they frequently form the basis of official policy, and they directly affect the way private and federal insurance providers cover the vaccines. “This is going to lead to an increase in preventable infections among children,” said Michaela Jackson, program director of prevention policy at the Hepatitis B Foundation. The vote is “removing choice by causing barriers to access” and “parents are not going to know who to trust any longer,” she said.
Hepatitis B vaccines are still recommended to children whose mothers test positive for the virus, the advisers said. The shots for most infants at birth will now be “shared clinical decision-making”, the advisers deciding, voting 8-3, although this is a term that is poorly defined and usually reserved for non-routine vaccines.
If a parent is not able to get their child the vaccine at birth, the advisers now suggest waiting at least two months.
www.theguardian.com
The CDC’s vaccine advisers have voted 8-3 to remove the broad recommendation that all newborns in the US receive a hepatitis B vaccine, in a major move signaling the Trump administration’s regressive approach to vaccines that have been given safely and effectively for decades.
The committee voted to recommend that parents of infants whose mothers test negative for hepatitis should decide when – or if – their child should receive the vaccine series, after consulting a healthcare professional.
The move will add confusion to routine vaccinations and create access issues, especially for lower-income families, experts said. While the advisers make non-binding recommendations, they frequently form the basis of official policy, and they directly affect the way private and federal insurance providers cover the vaccines. “This is going to lead to an increase in preventable infections among children,” said Michaela Jackson, program director of prevention policy at the Hepatitis B Foundation. The vote is “removing choice by causing barriers to access” and “parents are not going to know who to trust any longer,” she said.
Hepatitis B vaccines are still recommended to children whose mothers test positive for the virus, the advisers said. The shots for most infants at birth will now be “shared clinical decision-making”, the advisers deciding, voting 8-3, although this is a term that is poorly defined and usually reserved for non-routine vaccines.
If a parent is not able to get their child the vaccine at birth, the advisers now suggest waiting at least two months.
CDC advisory panel votes to limit hepatitis B vaccines for newborns
Move from CDC advisers mirrors Trump team’s regressive approach to longstanding vaccine guidance
